BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 25430073)

  • 1. Correlation between experimental human and murine skin sensitization induction thresholds.
    Api AM; Basketter D; Lalko J
    Cutan Ocul Toxicol; 2015; 34(4):298-302. PubMed ID: 25430073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive identification of human skin sensitization thresholds.
    Basketter DA; Clapp C; Jefferies D; Safford B; Ryan CA; Gerberick F; Dearman RJ; Kimber I
    Contact Dermatitis; 2005 Nov; 53(5):260-7. PubMed ID: 16283904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative relationship between the local lymph node assay and human skin sensitization assays.
    Schneider K; Akkan Z
    Regul Toxicol Pharmacol; 2004 Jun; 39(3):245-55. PubMed ID: 15135206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contact allergenic potency: correlation of human and local lymph node assay data.
    Gerberick GF; Robinson MK; Ryan CA; Dearman RJ; Kimber I; Basketter DA; Wright Z; Marks JG
    Am J Contact Dermat; 2001 Sep; 12(3):156-61. PubMed ID: 11526521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin sensitization testing in potency and risk assessment.
    Kimber I; Basketter DA; Berthold K; Butler M; Garrigue JL; Lea L; Newsome C; Roggeband R; Steiling W; Stropp G; Waterman S; Wiemann C
    Toxicol Sci; 2001 Feb; 59(2):198-208. PubMed ID: 11158712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of vehicle on the relative potency of skin-sensitizing chemicals in the local lymph node assay.
    Jowsey IR; Clapp CJ; Safford B; Gibbons BT; Basketter DA
    Cutan Ocul Toxicol; 2008; 27(2):67-75. PubMed ID: 18568891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel approach for classifying chemicals according to skin sensitizing potency by non-radioisotopic modification of the local lymph node assay.
    Takeyoshi M; Iida K; Shiraishi K; Hoshuyama S
    J Appl Toxicol; 2005; 25(2):129-34. PubMed ID: 15744759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Assessment of residual monomer migrating from acrylic polymers and causing Allergic Contact Dermatitis during normal handling and use.
    Pemberton MA; Lohmann BS
    Regul Toxicol Pharmacol; 2014 Aug; 69(3):467-75. PubMed ID: 24859074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducible prediction of contact allergenic potency using the local lymph node assay.
    Basketter DA; Cadby P
    Contact Dermatitis; 2004 Jan; 50(1):15-7. PubMed ID: 15059097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the local lymph node assay in the evaluation of the sensitizing potential of pharmaceutical process intermediates.
    Durand G; de Burlet G; Virat M; Nauman BD
    Contact Dermatitis; 2003 Sep; 49(3):148-54. PubMed ID: 14678211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative sensitizing potencies of fragrances, preservatives, and hair dyes.
    Lidén C; Yazar K; Johansen JD; Karlberg AT; Uter W; White IR
    Contact Dermatitis; 2016 Nov; 75(5):265-275. PubMed ID: 27633650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin sensitization potency of methyl methacrylate in the local lymph node assay: comparisons with guinea-pig data and human experience.
    Betts CJ; Dearman RJ; Heylings JR; Kimber I; Basketter DA
    Contact Dermatitis; 2006 Sep; 55(3):140-7. PubMed ID: 16918612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of BALB/c mouse in the local lymph node assay:BrdU-ELISA for the prediction of the skin sensitizing potential of chemicals.
    Hou F; Xing C; Li B; Cheng J; Chen W; Zhang M
    J Pharmacol Toxicol Methods; 2015; 72():53-8. PubMed ID: 25600862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the local lymph node assay for the estimation of relative contact allergenic potency.
    Basketter DA; Balikie L; Dearman RJ; Kimber I; Ryan CA; Gerberick GF; Harvey P; Evans P; White IR; Rycroft RJ
    Contact Dermatitis; 2000 Jun; 42(6):344-8. PubMed ID: 10871098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of allergenicity of some cosmetic mixtures by using ex vivo local lymph node assay-BrdU endpoints.
    Ulker OC; Kaymak Y; Karakaya A
    Int Arch Allergy Immunol; 2014; 164(4):301-7. PubMed ID: 25247696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human potency predictions for aldehydes using the local lymph node assay.
    Basketter DA; Wright ZM; Warbrick EV; Dearman RJ; Kimber I; Ryan CA; Gerberick GF; White IR
    Contact Dermatitis; 2001 Aug; 45(2):89-94. PubMed ID: 11553118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin sensitization potency of isoeugenol and its dimers evaluated by a non-radioisotopic modification of the local lymph node assay and guinea pig maximization test.
    Takeyoshi M; Iida K; Suzuki K; Yamazaki S
    J Appl Toxicol; 2008 May; 28(4):530-4. PubMed ID: 17929237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals.
    Gerberick GF; Ryan CA; Dearman RJ; Kimber I
    Methods; 2007 Jan; 41(1):54-60. PubMed ID: 16938465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of application vehicle on skin sensitization to methylchloroisothiazolinone/methylisothiazolinone: an analysis using the local lymph node assay.
    Warbrick EV; Dearman RJ; Basketter DA; Kimber I
    Contact Dermatitis; 1999 Dec; 41(6):325-9. PubMed ID: 10617213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proposal for a risk assessment methodology for skin sensitization based on sensitization potency data.
    Griem P; Goebel C; Scheffler H
    Regul Toxicol Pharmacol; 2003 Dec; 38(3):269-90. PubMed ID: 14623479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.